553 related articles for article (PubMed ID: 15782118)
21. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
22. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening.
Bessa X; Ballesté B; Andreu M; Castells A; Bellosillo B; Balaguer F; Castellví-Bel S; Paya A; Jover R; Alenda C; Titó L; Martinez-Villacampa M; Vilella A; Xicola RM; Pons E; Llor X;
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):206-14. PubMed ID: 18096441
[TBL] [Abstract][Full Text] [Related]
23. HNPCC: six new pathogenic mutations.
Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W
BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
25. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
26. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
[TBL] [Abstract][Full Text] [Related]
28. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
[TBL] [Abstract][Full Text] [Related]
29. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
[TBL] [Abstract][Full Text] [Related]
30. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer.
Krüger S; Plaschke J; Pistorius S; Jeske B; Haas S; Krämer H; Hinterseher I; Bier A; Kreuz FR; Theissig F; Saeger HD; Schackert HK
Hum Mutat; 2002 Jan; 19(1):82. PubMed ID: 11754112
[TBL] [Abstract][Full Text] [Related]
31. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
33. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
[TBL] [Abstract][Full Text] [Related]
34. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
[TBL] [Abstract][Full Text] [Related]
36. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
37. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
[TBL] [Abstract][Full Text] [Related]
38. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
Alazzouzi H; Domingo E; González S; Blanco I; Armengol M; Espín E; Plaja A; Schwartz S; Capella G; Schwartz S
Hum Mol Genet; 2005 Jan; 14(2):235-9. PubMed ID: 15563510
[TBL] [Abstract][Full Text] [Related]
39. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
Goel A; Xicola RM; Nguyen TP; Doyle BJ; Sohn VR; Bandipalliam P; Rozek LS; Reyes J; Cordero C; Balaguer F; Castells A; Jover R; Andreu M; Syngal S; Boland CR; Llor X
Gastroenterology; 2010 May; 138(5):1854-62. PubMed ID: 20102720
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?
Ollikainen M; Abdel-Rahman WM; Moisio AL; Lindroos A; Kariola R; Järvelä I; Pöyhönen M; Butzow R; Peltomäki P
J Clin Oncol; 2005 Jul; 23(21):4609-16. PubMed ID: 15837969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
